BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Trials

Illumina and HaploX Collaborate on Benchtop Sequencing System

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...

December 13, 2023 | News

Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate

Clover Biopharmaceuticals, Ltd.  a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...

December 13, 2023 | News

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...

December 13, 2023 | News

First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging

The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...

December 12, 2023 | News

CStone's Sugemalimab Granted NMPA Approval for Esophageal Cancer

Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy...

December 11, 2023 | News

Regor Reports Positive Results for RGT-419B in Advanced Breast Cancer After CDK4/6 Inhibitor and Endocrine Therapy

RGT-419B, a next generation CDK4 inhibitor, was safe and well tolerated in a First-in-Human Phase 1A single agent dose escalation s...

December 08, 2023 | News

Innovent Biologics and Synaffix Expand ADC Collaboration Amid Promising Phase 1 Results

The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...

December 07, 2023 | News

ObvioHealth and Chemist Warehouse Partner to Power Clinical Trial Efficiency in Australia

The partnership gives sponsors easier access to a wider pool of participants by driving awareness about trials to Chemist Warehouse's customers in Australi...

December 06, 2023 | News

Sirnaomics Successfully Completes Phase I Study for Anticoagulant RNAi Therapeutic STP122G

Cohort 1 is comprised of eight subjects who completed dosing and were followed over a period of 140 days. Safety data showed there were no dose-limiting to...

December 06, 2023 | News

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...

December 05, 2023 | News

Insilico Medicine Launches First Human Study for ISM5411, Oral PHD Inhibitor for IBD

ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...

December 05, 2023 | News

Clarivate and VeriSIM Life Strengthen Collaboration for Efficient Drug Development

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, ...

December 05, 2023 | News

Alecensa by Roche Cuts Risk in Asian ALK-Positive Lung Cancer Patients by Over 60%.

ALINA is the first and only Phase III study to show an improvement in disease-free survival in patients from Asia with early-stage resected ALK-posit...

December 04, 2023 | News

AWS and Accenture Aid Merck in Cloud-Powered Drug Discovery and Clinical Trial Acceleration

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...

November 30, 2023 | News

Stay Connected